The major glycoprotein complex gl of bovine herpesvirus-l was expressed at high levels (36 pg per 1 x 1 O6 cells) in insect cells using a recombinant baculovirus. The recombinant gl had an apparent molecular weight of 116 kDa and was partially cleaved to yield 63-kDa (glb) and 52-kDa (glc) subunits. This processing step was significantly less efficient in insect cells than the analogous step in mammalian cells, even though the cleavage sites of authentic and recombinant gl were shown to be identical. 
INTRODUCTION
Bovine herpesvirus-l (BHV-1) gl belongs to a group of homologous glycoproteins that have been detected in all herpesviruses analyzed to date. The prototype for this family of glycoproteins is gB of herpes simplex virus (HSV) (Pellett et a/., 198513; Bzik et al., 1986) . Glycoproteins with homology to gB have been described for human cytomegalovirus (HCMV) (Cranage et a/., 1986), varicella zoster virus (VZV) (Keller et al., 1986) , Epstein-Barr virus (EBV) (Pellett et al., 1985a) , pseudorabies virus (PRV) (Robbins et a/., 1987) BHV-1 (Whitbeck et a /., 1988; Misra et al., 1988) BHV-2 (Hammerschmidt et al., 1988) , equine herpesvirus-l (EHV-1) (Whalley et al., 1989) , EHV-4 (Riggio et al., 1989) , Marek's disease virus (Ross et al., 1989) , herpesvirus of turkeys (Buckmaster et al., 1988) , and herpesvirus saimiri (Albrecht and Fleckenstein, 1990) . These glycoproteins show a high degree of homology at the DNA, protein, and structural level, which suggests that they play a central role in the biology of herpesviruses. This is underscored by the observation that HSV gB and PRV gll are essential for viral replication (Cai et al,, 1987; Rauh et al., 1991) . On the basis of the high degree of homology between the gB homologs, it is very likely that BHV-1 gl is an indispensible glycoprotein.
A number of functions have been ascribed to this glycoprotein, among which are a role in attachment and penetration into susceptible cells (Liang eta/., 1991), induction of cell-cell fusion (Fitzpatrick eta/., 1988 (Fitzpatrick eta/., , 1990b , and the induction of neutralizing antibodies (van Drunen Littel-van den Hurk and Babiuk, 1985) . It is also a major target for the immune response of the host during BHV-1 infection (Collins et a/., 1985; van Drunen Littel-van den Hurk and Babiuk, 1986a) and it confers protection from BHV-1 challenge in cattle (Babiuk et al., 1987; van Drunen Littel-van den Hurk et a/., 1990a) , which makes it a suitable subunit vaccine candidate.
Mature gl consists of three related polypeptides that are derived from a common 105-kDa primary translation product. After glycosylation the precursor is cleaved by a cellular protease into two smaller glycoproteins of 74 and 55 kDa that are covalently linked by disulfide bonds (Marshall et al., 1986; van Drunen Lit- tel-van den Hurk and Babiuk, 198613) . The proteolytic cleavage process, however, is not complete, which results in the presence of a 130-kDa uncleaved glycoprotein in BHV-1 infected cells. The homologs of other herpesviruses, like VZV gpll (Montalvo and Grose, 1987) HCMV gB (Britt and Vugler, 1989; Spaete eta/., 1990) , EBV gB (Pellett eta/., 1985a), PRV gll (Lukacs et al., 1985; Mettenleiter et a/., 1986) , and EHV-1 and EHV-4 gB (Whalley et al., 1989; Meredith et a/., 1989) , show similar proteolytic processing of the primary translation product. Interestingly, the HSV homolog gB is not processed proteolytically. Nevertheless, the gB homologs are highly conserved among the herpesvirus family. As such, they are the only glycoproteins that exhibit a significant degree of structural conservation and immunological cross-reactivity (Davison and Tay lor, 1987; Misra et al., 1988) .
Our objective was to synthesize enough gl for structural, functional, and immunological analyses of this essential and highly conserved glycoprotein. In recent years the cloned BHV-1 gl gene has been expressed in a number of different vectors, including Escherichia co/i bacteria (Zamb, unpublished data) and vaccinia virus (van Drunen Littel-van den Hurk et a/., 1989). Disadvantages of these systems include loss of immunogenicity of E. co/i-produced gl and low yields of gl in vaccinia-virus-infected cells. Among other expression systems, those derived from the insect virus Autographa californica nuclear polyhedrosis virus (AcNPV) have proven to be valuable for foreign gene expression both in terms of the yields of the expressed protein and in the conservation of the biological properties of the derived protein (Luckow and Summers, 1988) . Unfortunately, insect cells do not always authentically glycosylate and process the heterologous protein, resulting in aberrant forms with altered immunogenicity.
Expression of the gl gene of BHV-1 in baculovirus resulted in the production of very high levels of gl. Although the recombinant gl was neither glycosylated nor cleaved as efficiently as the authentic gl, several of its functional, antigenic, and immunogenic properties were similar to those of authentic gl. It was transported to the cell surface and it mediated cell fusion. Affinity-purified recombinant gl induced the same level of antibodies in cattle as authentic gl. The availability of large amounts of gl will facilitate further studies on its function and potential as a subunit vaccine to BHV-1.
MATERIALS AND METHODS

Cells, viruses, and antibodies
Madin Darby bovine kidney (MDBK) cells were cultured in Eagle's minimal essential medium (Grand lsland Biological Co., Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) (GIBCO stocks of BHV-1 strain Cooper were,grown in MDBK cells as previously described (Babiuk et a/., 1975) . Spodoptera frugiperda (Sf9) cells were grown and maintained in TNM-FH medium (GIBCO) containing 100/o FBS according to the procedures described by Summers and Smith (1987) . Virus stocks of wild-type AcNPV and recombinant virus were prepared in Sf9 cells as described by Summers and Smith (1987) . Monoclonal antibodies specific for gl were developed and characterized by van Drunen Littel-van den Hurk et a/. (1984) . The gl-specific monoclonal antibody mixture used for identification of recombinant gl consisted of equivalent amounts of 1 BlO (epitope I), 3F3 (epitope II), 1 El 1 (epitope Ill), 1 F8 (epitope IVa), 5G2 (epitope IVb), 3Gl 1 (epitope IVb), 5Gl 1 (epitope IVc), 6Gl 1 (epitope IVc), 1 FlO (epitope V), and 2C5 (epitope V).
Insertion of BHV-1 gl DNA into the transfer vector
A cassette of the gl glycoprotein gene has been prepared in plasmid pSV2Neo as previously described (Fitzpatrick et al., 1988) . The plasmid was digested with restriction endonuclease Bglll and the fragment representing the gl gene was purified by agarose gel electrophoresis and ligated into the BarnHI site of the baculovirus transfer vector pVL941 to form the expression vector pVLgB. The pVLgB plasmid was purified for transfection by CsCl gradient centrifugation and two cycles of ethanol precipitation.
Transfection and selection of recombinant viruses
The purified plasmid was mixed with an equal amount of A. californica viral DNA and used to transfeet subconfluent monolayers of Sf9 cells as outlined by Summers and Smith (1987) . Recombinant baculoviruses were identified by plaque hybridization essentially as outlined by Summers and Smith (1987) . The polyhedrin-negative recombinants were plaque purified three to four times on Sf9 cells to remove contaminating wild-type virus.
Preparation of cell lysates and immunoprecipitation
To analyze expression of recombinant gl, confluent monolayers of Sf9 cells on 35-mm petri dishes were infected with individual polyhedrin-negative recombinants at a m.o.i. of 5 and incubated for 48 hr at 28". The cells were scraped into PBS, pelleted at 150 gfor 1 min, and resuspended in 50 ~1 of RIPA buffer (0.02 M Tris-hydrochloride [pH 8.01, 0.15 M NaCI, 1% sodium deoxycholate, 1% nonidet P-40, 10 mM ethylene diamine tetraacetic acid [EDTA], 10 mM phenylmethylsulfonylfluoride
[PMSF]). The supernatant was collected and 5 ~1 was combined with reducing electro- phoresis sample buffer and boiled for 2 min for analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting.
For immunoprecipitation, BHV-l-infected MDBK cells were overlaid with methionine-free MEM containing lo/o FBS, labeled at 6 hr postinfection with 50 &i per ml of [L-35S]methionine (Amersham, Oakville, Ontario) and harvested at 24 hr post-infection. Bat-gl infected cells were overlaid at 16 hr postinfection with methioninefree TNM-FH medium containing loo/o FBS, labeled with 100 $Zi per ml of [L-35S]methionine 1 hr later, and harvested at 19 hr postinfection. Tunicamycin at 10 pg per ml was added with the methionine-free medium. lmmunoprecipitation with a gl-specific monoclonal antibody cocktail was performed as described previously (van Drunen Littel-van den Hurk et al., 1984) .
Analysis of carbohydrates
Proteins were digested with endoglycosidase H or glycopeptidase F as described by Ronin et al. (1987) . Infected cells were collected by centrifugation and 2 x 1 O5 cells were resuspended in 10 ~1 of appropriate en-zyme incubation buffer, Digestion with glycopeptidase F (Boehringer-Mannheim, Laval, Quebec, Canada) was performed in 50 mM Tris-hydrochloride (pH 8.6) 25 mM EDTA, 1% Triton X100, 1% 2-mercaptoethanol, 0.2% SDS and 1.5 U of enzyme. Digestion with endo H (Boehringer-Mannheim) was performed in 0.1 M sodium acetate (pH 5), 0.15 M sodium chloride, 1% Triton Xl 00, 1 O/o 2-mercaptoethanol, 0.2% SDS, and 1.5 mU of enzyme. The cells were incubated for 18 hr at 37°C. Proteins were precipitated by adding 1 ml of ice-cold acetone and centrifugation and subjected to SDS-PAGE followed by immunoblot analysis.
SDS-PAGE, Immunoblot,
and ELISA SDS-PAGE was performed under reducing conditions in 7.5, 8.5, or 10% polyacrylamide discontinuous gels as previously described (van Drunen Littel-van den Hurk et a/., 1984). Protein bands were visualized by staining with coomassie brilliant blue.
In order to identify recombinant gl produced by baculovirus, immunoblot assays were performed as previously described (van Drunen Littel-van den Hurk et al., 1984). Briefly, after electrophoresis cell lysates were electrophoretically transferred to nitrocellulose sheets. Subsequently, the instructions for use of the Bio-Rad (Mississauga, Ontario) immunoblot assay kit were followed.
One gl-positive recombinant baculovirus, named Bat-gl, was amplified by growth on Sf9 cells. The supernatants from this infection were stored at 4" and used in all subsequent experiments.
Sandwich ELlSAs were used to determine the yields of glycoprotein gl in recombinant baculovirus-infected Sf9 cells. Sf9 cells in monolayers or suspension cul-tures were infected with recombinant virus at a m.o.i. of 1. Suspension cultures were grown in 500-ml spinner flasks at a cell density of 1 X 1 O6 cells/ml. The cells were harvested at various times postinfection, washed with PBS, and resuspended in RIPA buffer at 1 X 1 O7 cells/ml for analysis by ELISA. Equivalent samples from uninfected cells and/or cells infected with the parental virus were always included as controls. Microtiter plates were coated with the IgG fraction of bovine hyperimmune serum as the capture antibody and then incubated with serial dilutions of lysates from recombinant-virus-infected and control cells, or affinity-purified standard gl. Indirect ELlSAs were used to analyze the antigenic properties of recombinant gl as compared to those of authentic gl. In the indirect assay, the cell lysates and glycoproteins were adsorbed to the microtiter plates. Mixtures or individual gl-specific monoclonal antibodies, followed by horseradish peroxidase (HRPO) conjugated goat anti-mouse IgG (Boehringer-Mannheim) were used for detection as previously described (van Drunen Littel-van den Hurk et al., 1984) . The reaction was visualized using 0.8 mg/ml of 5-aminosalicylic acid and 0.006% H,O, as described.
Protein sequencing N-terminal sequencing of the glb and glc components of affinity-purified authentic and recombinant gl was performed by Edman degradation with an Applied Biosystems Model 470A gas phase sequenator equipped with an on-line model 120 PTH amino acid analyzer.
lmmunofluorescence and flow cytometry
The expression of glycoprotein gl in recombinantbaculovirus-infected Sf9 cells was determined at 24, 48, and 72 hr postinfection. Briefly, cells were washed in PBS and cytospin smears were prepared and fixed in methanol. They were incubated for 30 min at 37" with a 1: 100 dilution of a gl-specific monoclonal antibody mixture and washed in PBS and ddH,O. They were stained with fluorescein-isothiocyanate-conjugated (FITC) rabbit anti-mouse IgG (Boehringer-Mannheim) for 30 min at 37" and washed again before being mounted in PBS-glycerol for examination. For surface staining and flow-cytometric analysis, cells were suspended in PBS containing 0.2% gelatin and 0.03% NaN, (PBSG) at 4 x 1 O7 cells/ml. They were plated in microtiter plates at 2 X 1 O6 cells per well and incubated with serial dilutions of monoclonal antibody mixtures for 30 min on ice. Subsequently, they were washed in PBSG and then incubated with FITC rabbit anti-mouse IgG for 30 min at 4". After washing, the cells were fixed in 2% formaldehyde and analyzed with an EPICS CS (Coulter Electronics, Ltd.) flow cytometer as described elsewhere (Campos et al., 1989) . The percentage of positive cells was calculated using the immuno-program (Coulter Electronics, Ltd., MDAPS system) for the analysis of immunofluorescence histograms.
Cell fusion assay
Monolayers of Sf9 cells in 24-well tissue culture plates were infected with recombinant virus at a m.o.i. of 5-10 PFU per cell. At 36 hr post-infection, the medium was replaced with TNM-FH medium, adjusted to a pH ranging from 5.0 to 6.5. Syncytia formation was later. They were bled at the times of immunization and 2 weeks after the second immunization for assessment of antibody responses. The specificity of the antibody response to gl in the vaccinated animals was assayed in an immunoblot assay with purified BHV-1 as the antigen, as described previously (van Drunen Littelvan den Hurk et a/., 1990a). The level of the antibody response to gl was measured by ELISA with affinitypurified gl from BHV-1 infected cells as the antigen, as described previously (van Drunen Littel-van den Hurk et al., 1990a).
RESULTS
Production of recombinant gl glycoprotein in Sf9 cells
Recombinants containing the gl gene inserts were tested for their ability to produce BHV-1 glycoprotein I after infection of Sf9 cells. All of the gl recombinants directed the synthesis of a polypeptide with an apparent molecular weight of 1 16 kDa, which was visible on a Coomassie brilliant blue stained gel at 48 hr postinfection. This protein was missing in uninfected cells and cells infected with the parental baculovirus and probably represented recombinant glycoprotein gla. Three additional polypeptides appeared during infection with the gl recombinants. The 63-and 52-kDa poly-peptides probably corresponded to the glb and glc components of the recombinant glycoprotein (Fig. 1) . In order to confirm the identity of these glycoproteins, immunoblot analyses were performed on Bac-gl-infected Sf9 cells and BHV-l-infected MDBK cells (Fig.  2) . A gl-specific monoclonal antibody mixture that recognized the 130k, 74k, and 55k components of authentic gl in BHV-1 -infected MDBK cells, reacted with three polypeptides with apparent molecular weights of 1 16, 63, and 52 kDa in Bat-gl-infected Sf9 cells. The 38-kDa polypeptide, observed in Fig. 1 , was either a gl fragment not detected by gl-specific monoclonal antibodies, or a baculovirus-specified polypeptide. These data suggest that terminal glycosylation of gl has not occurred in the recombinant virus-infected Sf9 cells. Although recombinant gl was cleaved in infected Sf9 cells, the efficiency of cleavage was lower than that of authentic gl.
Processing of gl in mammalian and insect cells
To further analyze the observed difference in molecular weight of the recombinant and authentic gl, Bac-glinfected Sf9 cells, and BHV-l-infected MDBK cells were treated with tunicamycin, an inhibitor of N-linked glycosylation. In these cells only one polypeptide with an apparent molecular weight of 105k was observed (Fig. 3A) , which corresponds to the previously identi-LITTEL-VAN DEN HURK, ET AL.
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fied polypeptide backbone of authentic gl (van Drunen Littel-van den Hurk and Babiuk, 1986b). This experiment proved that the decreased molecular weight of gl produced in insect cells was due to altered glycosylation. Due to the short labeling period, the recombinant glb and glc were not observed on this gel. To compare the type of carbohydrate attached to recombinant and authentic gl, both glycoproteins were subjected to di-gestion with endo H or endo F. Digestion with endo H resulted in a slight decrease in apparent molecular weight of authentic gla and glc, but had no effect on glb, which confirms previous studies (van Drunen Littel-van den Hurk et al., 1986b) . The greater portion of recombinant gla and glc was sensitive to endo H, indicating the presence of high-mannose type oligosaccharides. In contrast, the recombinant glb was not sensitive to endo H, suggesting that these oligosaccharides were trimmed. All of the recombinant and authentic forms of gl were endo-F-sensitive, showing precursor molecules with similar apparent molecular weights in BHV-1 and Bat-gl-infected cells (Fig. 3B ). Authentic and recombinant gl are both cleaved during processing to the mature polypeptide. However, the cleavage process is incomplete in mammalian cells and even less efficient in insect cells. It has been proposed that the Arg-Arg-Ala-Arg-Arg sequence (50 l-505), which occurs in the region of nonsimilarity with HSV-1, may be the processing site for BHV-1 gl (Whitbeck et al., 1988) . To confirm the position of the cleavage site of authentic as well as recombinant gl, we sequenced the N-terminus of the glc glycoprotein from infected MDBK and Sf9 cells. This analysis confirmed that the first 12 N-terminal amino acids of authentic and recombinant glc correspond to positions 506-517 ( Fig. 4 ). Since recombinant gl was cleaved at the same site as authentic gl, the reduced cleavage efficiency is probably due to the presence of relatively low amounts of enzyme in baculovirus-infected cells, as compared to the large amounts of gl produced in these cells. N-terminal sequencing of the glb glycoprotein demonstrated that the same signal is cleaved in MDBK and Sf9 cells and that the amino terminal residue of authentic as well as recombinant gl is Arg-68.
Kinetics and level of expression of the recombinant gl glycoprotein
The amount of gl synthesized in recombinant baculovirus-infected Sf9 cells was quantitated by ELISA standardized with affinity-purified recombinant gl. Sf9 cells grown as monolayers in 35-mm petri dishes were infected with Bat-gl at a m.o.i. of 5, and aliquots of 1 X 10" cells were harvested at various times postinfection. lmmunoreactive gl could be detected as early as 24 hr after infection and maximal expression was observed between 36 and 48 hr, thereafter, a slight decrease in measurable glycoprotein occurred. This decline presumably reflects cell lysis and subsequent degradation of the glycoprotein. This analysis showed that, at maximal levels of expression, 28 pg of gl were produced per 1 O6 cells (Fig. 5A ). In order to analyze the possibility of producing recombinant gl on a larger scale, Sf9 cells were grown in suspension cultures and infected with the recombinant baculovirus at a m.o.i. of 1. In addition to yield by ELISA, the viability of the cells and percentage of infected cells were determined. Figure 5B shows that the percentage of infected cells increased gradually, reaching peak levels of 85% at 72 hr after infection, when the viability of the cells was down to 25%. The viability of the cells was too low for flow , 1985) . ' Neutralizing titers were determined for ascites fluids in the presence of guinea pig serum as a source of complement.
-, titer i 4; -t, titer < 100; f, titer > 100; ff, titer > 10,000 (van Drunen Littel-van den Hurk er al., 1985) .
'Antigen titer was expressed as the reciprocal of the highest dilution of infected cells giving a reading of at least 0.05 OD (492 nm). A 1 :lOO dilution corresponds to 2 X 1 O4 cells. 
Intracellular localization of recombinant gl in Sf9 cells
The intracellular distribution of the recombinant gl glycoprotein was examined by an indirect immunofluorescence assay. At 48 hr postinfection, recombinant gl was primarily localized in the perinuclear membranes of the infected Sf9 cells (Fig. 6a) . To determine whether the recombinant gl was present on the surface of infected cells, immunofluorescence analysis was carried out on unfixed cells. Localization of gl on the cell surface was demonstrated by bright surface fluorescence (Fig. 6b ). Wild-type AcNPV-infected control cells did not show any fluorescence with the gl-specific monoclonal antibody panel (not shown).
Fusogenic properties of recombinant gl in insect cells
It has been shown previously that one of the functional characteristics of gl is its ability to induce cell fusion in absence of other viral proteins (Fitzpatrick et al., 1988 (Fitzpatrick et al., , 1990b . To determine whether the recombinant protein retained this functional property, Sf9 cells were infected with Bat-gl. Fusion of the insect cells was not evident under standard culture conditions (Fig.  7a ), but after a shift to pH 5.4 fusion was apparent in Bat-gl-infected Sf9 cells within 2 hr (Fig. 7b) . The syncytia formation observed in these cells continued to increase over 8 hr of observation (Fig. 7~) . Fusion was not detected in cultures infected with wild-type AcNPV over the pH range examined (not shown). Inclusion of gl-specific rabbit serum or a mixture of gl-specific monoclonal antibodies completely inhibited fusion by gl (Table 1) . When individual monoclonal antibodies were included in the media, fusion was almost completely inhibited by the monoclonal antibodies 1 BlO (epitope I) and 5G2 (epitope IVb) and partially inhibited by 5Gl 1 (epitope IVc). Inclusion of trypsin at the time of pH shift did not affect the fusion activity.
Antigenic and immunogenic properties of gl expressed in Sf9 cells
The antigenic properties of recombinant gl were evaluated using a panel of gl-specific monoclonal antibodies. The epitopes recognized by these monoclonal antibodies have been identified and characterized previously (van Drunen Littel-van den Hurk et al., 1985; Fitzpatrick et al., 1990a) . The reactivity of these monoclonal antibodies in an ELISA (Table 2) indicated that all of the epitopes identified on the authentic glycoprotein were also present on the recombinant gl glycoprotein. The reaction between the monoclonal antibodies and two carbohydrate-dependent epitopes (IVa and IVc; van Drunen Littel-van den Hurk et al., 1990b) was weaker on recombinant gl than on authentic gl, which is in agreement with lack of terminal glycosylation of gl in Sf9 cells. Epitopes I, II, and III, however, appeared to be more reactive on recombinant gl than on its authentic counterpart.
To compare the immunogenicity of recombinant and authentic gl, calves were immunized with affinity-purified glycoprotein from recombinant Bat-gl-infected Sf9 cells or BHV-l-infected MDBK cells. Two immunizations of recombinant or authentic gl in Emulsigen PLUS elicited antibodies that were reactive with gl from BHV-1 in an immunoblot assay (Fig. 8) . The antibody titers induced by recombinant and authentic gl were very similar (Table 3) .
DISCUSSION
The goal of this study was to determine whether the baculovirus system would produce gl in an authentic form and in sufficient quantities for further structural, functional, and immunological analyses. The level of gl synthesis attained by using the baculovirus expression vectorwas extremely high, about 36 pg per 1 O6 cells by 48-72 hr postinfection. This amount is at least 1 O-fold greater than the quantity of gl glycoprotein found in BHV-l-infected cells (van Drunen Littel-van den Hurk and Babiuk, 1985) , which makes this system the most efficient means for producing gl.
BHV-1 gl has six potential receptor sites for N-linked glycosylation of which one is probably not used (Whitbeck et al., 1988) . The apparent molecular weight of the gl complex was 116/63/52 kDa in insect cells, which corresponds in size to the cotranslationally glycosylated gl produced in BHV-l-infected MDBK cells (van Drunen Littel-van den Hurk and Babiuk, 198613) . Authentic gl is processed post-translationally into the mature 130/74/55-kDa complex. The pol,ypeptide backbones of recombinant and authentic gl were both 105 kDa, proving that indeed the lower apparent molecular weight of the recombinant form was clue to altered processing of the carbohydrates in insec:t cells. A portion of the recombinant gl was resistant to endo H cleavage which confirms earlier reports that N-glycans can be trimmed in insect cells to trimannosyl cores, without further elongation (Butters et a/., 198'1; Hsieh and Robbins, 1984) . The majority of the oligosaccharide side chains on the recombinant gl, however, contained endo-H-sensitive linkages, which was in agreement with studies on HCMV gB (Wells et a/., 1990), influenza virus hemagglutinin (Kuroda et a/., 1986 (Kuroda et a/., , 1990 , human immunodeficiency virus gpl60 (Wells and Compans, 1990) , and hepatitis B virus surface antigen (Lanford et a/., 1989), which also ciontained mostly endo-H-sensitive carbohydrates when produced in insect cells.
In spite of being incompletely glycosylated, recombinant gl was proteolytically cleaved into its two sub-units, albeit less efficiently than authentic gl. The enzymatic machinery executing cleavage of most of the gB homologs is still largely unknown. Recently it has been shown that a protease located in the Golgi apparatus is responsible for PRV gll processing (Whealy et a/., 1990). As the exact cleavage site for BHV-1 gl has not been determined yet, we sequenced the N-terminal portion of glc from insect cells and mammalian cells. The cleavage site was, as anticipated, between residues 505 and 506, just after the Arg-Arg-Ala-Arg-Arg motif proposed to be the processing site (Whitbeck et a/., 1988) . This consensus cleavage signal is identical in PRV gll (Wolfer et al., 1990) , although the N-terminal sequences of BHV-1 glc and PRV gllc show considerable heterogeneity (Misra et a/., 1988). Thus, the inefficiency with which recombinant gl is cleaved is not due to a difference in the processing site. The slow rate of cleavage of the gl glycoprotein observed in insect cells is in agreement with observations made on other glycoproteins like the influenza hemagglutinin (Kuroda et al., 1986 (Kuroda et al., , 1990 , the E2 protein of mouse hepatitis virus (Yoden eta/., 1989), the gpl60 of human immunodeficiency virus (Wells and Compans, 1990) , the F glycoprotein of measles virus (Vialard et a/., 1990) and the gB glycoprotein of HCMV (Wells et al., 1990) . This may reflect the presence in insect cells of low levels of a host cell protease involved in processing of these glycoproteins, or alternatively, the presence of normal levels of the protease which, however, is saturable and unable to process the large amounts of glycoprotein produced in these cells. Another explanation is based on the observation that a portion of recombinant gl remains endo-H-sensitive and thus may not migrate from the ER to the Golgi (Lanford et a/., 1989), where cleavage probably occurs.
The recombinant gl glycoprotein was transported to and expressed on the surface of infected cells, and as such, was capable of inducing cell-to-cell fusion. This indicates that complete glycosylation is not needed for fusion activity. Although it is not known whether the gl molecules expressed on the surface of the infected cells are cleaved or not, addition of trypsin did not enhance syncytia formation, indicating that the fusion activity is not totally dependent upon cleavage of gl. Optimal conditions for fusion appeared to be more acidic in insect cells than in mammalian cells (Fitzpatrick et al., 1990b) . This phenomenon has been observed for different fusion proteins expressed in insect cells, like the F protein of measles virus and the S glycoprotein of bovine coronavirus (Vialard et a/., 1990; Yoo et a/., 1990). The glycosylation differences observed in all cases may be responsible for conformational changes resulting in the altered optimum pH for fusogenicity. In addition, the membranes of insect and mammalian VAN DRUNEN LITi-EL-VAN DEN HURK, ET AL cells may differ as targets for fusion. That fusion was mediated by gl was confirmed by total inhibition in the presence of gl-specific polyclonal or a cocktail of monoclonal antibodies. Monoclonal antibody 1 BIO, specific for epitope I( inhibited fusion almost completely. Epitope I maps to a segment between residues 744-763, a highly conserved portion of the extracellular region of the carboxy terminal fragment (glc) of gl (Fitzpatrick et a/., 1990a) . This implies that one domain responsible for cell fusion is located on the glc subunit, between or in the vicinity of residues 744-763. Monoclonal antibody 5G2, specific for epitope IVb, and monoclonal antibody 5G11, specific for epitope IVc, partially inhibited fusion activity. These epitopes map to the amino terminus of gl between residues 68 and 119 (Fitzpatrick et a/., 1990a) . This suggests that domain IV is also involved in the fusion process. In analogy to the predicted secondary structure determined for gB (HSV) by Pellett et a/, (1985) , gl might also fold back, thereby positioning the amino terminus in close proximity to the membrane. Alternatively, fusion may be a complex process which requires the sequential or coordinated activity of at least two separate domains of gl. To exclude the possibility that the monoclonal antibodies specific for epitopes I and IV inhibit fusion indirectly, both fusogenie regions need to be confirmed by mutagenic analysis. This is the first report implying domains I and IV of BHV-1 gl in the fusion process. Recently, three domains involved in fusion activity of HSV-1 gB were identified (Navarro et a/., 1992). Two of these, Dl and D5a, correspond to the amino terminal domain IV and the carboxy terminal domain I of BHV-1 gl, respectively.
In addition to the structural and functional analyses of recombinant gl, we studied the antigenicity by ELISA. BHV-1 gl has at least four neutralizing and three weakly or nonneutralizing epitopes, some of which are conformational in nature (van Drunen Littel-van den Hurk et al,, 1985; Fitzpatrick et al., 1990a) . All of these epitopes were recognized on recombinant gl. The reaction with two carbohydrate-dependent epitopes, IVa and IVc, appeared weaker and the recognition of epitopes I, II, and III seemed stronger, but in general the antigenicity was not significantly affected by altered processing and glycosylation. This is in contrast to the situation observed in the absence of carbohydrate, which does affect the antigenicity of gl (van Drunen Littel-van den Hurk et a/., 1990b). Altered processing and glycosylation of gl in insect cells did not affect the immunogenicity of gl. Immunization of cattle with purified recombinant or authentic gl led to the induction of similar levels of gl-specific antibodies in cattle.
This work has shown that BHV-1 gl produced by an AcNPV recombinant in insect cells is biologically, anti-genitally, and immunogenically active, despite the fact that it is incompletely cleaved and glycosylated. These properties indicate that recombinant gl has not undergone conformational rearrangements and should be an appropriate candidate for further structural, functional, and immunological analyses.
